STOCK MARKET BSE NSE

Andhra Pradesh running out of Remdesivir?

Manufacturers scaled down production due to losses after first Covid wave, say sources 

Published: 11th April 2021 02:32 AM  |   Last Updated: 11th April 2021 01:48 PM   |  A+A-

Early studies testing remdesivir in patients hospitalized with COVID-19 found that those who received the treatment recovered quicker than those who didn't.

Image used for representation.

Express News Service

VIJAYAWADA:  Now it has become more of a guessing game with regard to how long the stock of a drug used in the treatment of SARS-COV-2, commonly known as Covid-19, will last in the state. The sudden surge in its demand due to spiking infections and insufficient supply have led to this situation.Even as the state government has been sending one SOS after another to the Centre regarding vaccine supply, with the latest being Chief Minister YS Jagan Mohan Reddy’s letter to the prime minister seeking 25 lakh doses, the state is also expected to run out of Remdesivir soon. 

While sources in the health department say government hospitals treating Covid-19 patients have sufficient stock of the drug for now, but for how long is anyone’s guess. However, it is learnt that some private hospitals have been complaining of a deficit supply of Remdesivir. 

Vaccination drive underway at a Vijayawada ward
secretariat | Prasant Madugula

A private doctor, who wished to remain anonymous, said given the fall in the number of cases reported after the first wave, between November and March, the demand for the antiviral drug decreased, forcing manufacturers to scale down the production. 

However, the sudden spike in the cases has pushed up the demand for Remdesivir. According to sources in pharma distribution companies, companies involved in the production of Remdesivir suffered losses and decreased the production after the first wave, hence the shortage. 

With regard to the pricing, the drug is manufactured by two companies, and is priced at Rs 4,000 and Rs 5,400 per vial.  The Rs 4,000 drug is supplied at a discounted price to the government and other hospitals treating Covid-19 cases, and the discount varies (with the cheapest one priced at Rs 2,300). 

As the distributors themselves have low stock, there is little scope of getting Remdesivir over the counter at pharmacies. Most of the stocks are supplied only to the hospitals. However, the situation in AP is comparatively better than northern states that are seeing acute increase in Covid cases, but it would go there way if the issues are not resolved at the earliest, the sources said.


TAGS
remdesivir

Comments

Disclaimer : We respect your thoughts and views! But we need to be judicious while moderating your comments. All the comments will be moderated by the newindianexpress.com editorial. Abstain from posting comments that are obscene, defamatory or inflammatory, and do not indulge in personal attacks. Try to avoid outside hyperlinks inside the comment. Help us delete comments that do not follow these guidelines.

The views expressed in comments published on newindianexpress.com are those of the comment writers alone. They do not represent the views or opinions of newindianexpress.com or its staff, nor do they represent the views or opinions of The New Indian Express Group, or any entity of, or affiliated with, The New Indian Express Group. newindianexpress.com reserves the right to take any or all comments down at any time.

flipboard facebook twitter whatsapp